A randomised prospective study to evaluate laser peripheral iridotomy with YAG laser against sequential argon-YAG laser in dark irides

ISRCTN ISRCTN82666926
DOI https://doi.org/10.1186/ISRCTN82666926
Protocol serial number N0141184531
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Funder Moorfields Eye Hospital NHS Foundation Trust (UK), NHS R&D Support Funding
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
12/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Julian DeSilva
Scientific

Moorfields Eye Hospital
162 City Road
London
EC1V 2PD
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA randomised prospective study to evaluate laser peripheral iridotomy with YAG laser against sequential argon-YAG laser in dark irides
Study objectivesTo identify the advantages of combined argon-YAG laser iridotomy versus YAG laser alone, in patients of darkly pigmented irides.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEye Diseases: Pigmentation disorders
Intervention1. Pure YAG laser
2. Argon-YAG Laser
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Total YAG laser power utilised

Key secondary outcome measure(s)

1. Complications (iris haemorrhage, elevated intraocular pressure, intraocular inflammation, focal corneal opacity)
2. Patency of laser iridotomy after single treatment
3. Cost implications of 2 laser treatments versus need for failed iridotomy requiring a second treatment

Completion date22/01/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration30
Key inclusion criteria1. Require iridotomy in both eyes
2. Informed consent available
3. Can follow up after 3 months
4. Dark irides
Key exclusion criteria1. Previous failed laser iridotomy
2. History of previous intraocular pathology affecting iris morphology
3. Patients with only 1 functional eye or previous ACG
4. Patients with advanced glaucoma
5. Patients medically unfit for laser treatment
Date of first enrolment23/08/2006
Date of final enrolment22/01/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Moorfields Eye Hospital
London
EC1V 2PD
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2012 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

12/10/2017: Publication reference added.